Biodock key facts
as of Oct 2026- Developer of a cloud-based analysis platform designed to analyze and store biological data, including microscopy images.
- Biodock is valued at approximately $15.0M as of Oct 2026 (last reported valuation).
- It has raised $6.0M; the latest was Seed Round ($3.8M) in Nov 2025.
- Notable investors include Y Combinator, Andreessen Horowitz, Soma Capital, Operator Partners, TQ Ventures — 7 tracked in total.
- Status: Privately Held (backing).
Biodock's last reported valuation, Mar 2021. Nothing priced has surfaced since.
- ·Watch Biodock: the Monday email on marks, rounds and moves
Biodock funding rounds
No funding rounds for Biodock are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Biodock valuation
Biodock's last reported valuation was $15 million in Mar 2021. No priced round, secondary trade or fund mark has surfaced since.
Biodock investors
7 investors are on record for Biodock, including Y Combinator, Andreessen Horowitz, Soma Capital and Operator Partners.
About Biodock
Developer of a cloud-based analysis platform designed to analyze and store biological data, including microscopy images. The company's platform makes research painless by managing storage, running jobs in the cloud across powerful graphics processing units (GPU), and providing access through a user interface designed specifically for scientists, enabling clinicians to upload, analyze, and download quantification on a single-cell level and graphs in publication-ready formats.
- Sector
- Healthcare
- HQ
- Austin, TX, United States
- Founded
- 2020
- Employees
- 5
- Website
- biodock.ai/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.